| Abbreviation | Expansion |
| ABCA1 | ATP-binding cassette transporter A1 |
| ABCG1 | ATP-binding cassette transporter G1 |
| ADRs | adverse drug reactions |
| AEs | adverse events |
| ALP | alkaline phosphatase |
| ALT | alanine aminotransferase |
| ANCOVA | analysis of covariance |
| ATP | adenosine triphosphate |
| Apo | apolipoprotein |
| AST | aspartate aminotransferase |
| BMI | body mass index |
| CEC | cholesterol efflux capacity |
| CK | creatine kinase |
| CKD | chronic kidney disease |
| CM-C | chylomicron-cholesterol |
| CV | cardiovascular |
| eGFR | estimated glomerular filtration rate |
| FAS | full analysis set |
| FDA | Food and Drug Administration |
| FGF21 | fibroblast growth factor 21 |
| Hb | hemoglobin |
| HDL-C | high-density lipoprotein-cholesterol |
| HPLC | high-performance liquid chromatography |
| IL | interleukin |
| LDL-C | low-density lipoprotein-cholesterol |
| LOCF | last observation carried forward |
| LPL | lipoprotein lipase |
| LS | least squares |
| mRNA | messenger ribonucleic acid |
| NPC1L1 | Niemann-Pick C 1-Like-1 |
| PPARα | peroxisome proliferator-activated receptor α |
| RemL-C | remnant lipoprotein-cholesterol |
| sCr | serum creatinine |
| SPPARMα | selective peroxisome proliferator-activated receptor α modulator |
| TC | total cholesterol |
| TG | triglyceride |
| VCAM-1 | vascular cell adhesion molecule-1 |
| VLDL-C | very-low-density lipoprotein-cholesterol |
| γ-GT | gamma-glutamyltransferase |